We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
SNDK
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Zeta Global
ZETA
$7.73B
| $19.4M | 0.02% |
987,883
-1,313,874
| -57% | -$24.4M |
|
|
NXH
727
Neighborhood Intelligence Inc
NXH
$368M
| $19.4M | 0.02% |
3,355,562
+754,787
| +29% | +$4.14M |
|
728
Pfizer
PFE
$158B
| $19.3M | 0.02% |
802,396
-15,280,392
| -95% | -$400M |
|
729
Amphenol
APH
$202B
| $19.3M | 0.02% |
218,426
-4,456,194
| -95% | -$321M |
|
730
Kymera Therapeutics
KYMR
$9.68B
| $19.2M | 0.02% |
+167,517
| New | +$14.4M |
|
731
Walt Disney
DIS
$181B
| $19.2M | 0.02% |
199,219
-679,865
| -77% | -$69.3M |
|
732
CALL
Alphabet (Google) Class C
GOOG
$4.1T
| $19.2M | 0.02% |
54,200
-144,900
| -73% | -$51.8M |
|
733
Celcuity
CELC
$4.55B
| $19.1M | 0.02% |
182,156
+163,256
| +864% | +$18.8M |
|
734
Hexcel
HXL
$6.9B
| $19M | 0.02% |
190,238
+5,065
| +3% | +$459K |
|
735
Omega Healthcare
OHI
$14.3B
| $19M | 0.02% |
398,013
-694,503
| -64% | -$32.2M |
|
736
MINISO
MNSO
$2.8B
| $18.9M | 0.01% |
1,570,379
-375,277
| -19% | -$5.27M |
|
737
Coeur Mining
CDE
$21.2B
| $18.8M | 0.01% |
1,153,189
+987,297
| +595% | +$18M |
|
738
BP
BP
$116B
| $18.8M | 0.01% |
509,177
-187,964
| -27% | -$8.25M |
|
|
NUVL
739
DELISTED
Nuvalent
NUVL
| $18.8M | 0.01% |
152,122
+148,928
| +4,663% | +$16M |
|
740
Immunocore
IMCR
$1.82B
| $18.8M | 0.01% |
590,941
+410,601
| +228% | +$12.1M |
|
741
PUT
Delta Air Lines
DAL
$51.9B
| $18.7M | 0.01% |
200,000
-383,700
| -66% | -$29M |
|
742
Tyra Biosciences
TYRA
$1.6B
| $18.6M | 0.01% |
583,133
+385,385
| +195% | +$12.7M |
|
743
iShares Expanded Tech-Software Sector ETF
IGV
$13.9B
| $18.6M | 0.01% |
205,516
+137,228
| +201% | +$12.2M |
|
744
PUT
Oracle
ORCL
$468B
| $18.6M | 0.01% |
126,800
-49,100
| -28% | -$8.9M |
|
745
ACV Auctions
ACVA
$1.19B
| $18.5M | 0.01% |
2,578,386
+56,602
| +2% | +$321K |
|
746
PUT
Meta Platforms (Facebook)
META
$1.56T
| $18.5M | 0.01% |
32,900
+16,800
| +104% | +$10.3M |
|
747
American Healthcare REIT
AHR
$11.9B
| $18.5M | 0.01% |
+355,049
| New | +$17.4M |
|
748
Immix Biopharma
IMMX
$943M
| $18.5M | 0.01% |
1,794,908
+153,356
| +9% | +$1.42M |
|
749
Zoetis
ZTS
$30.4B
| $18.5M | 0.01% |
257,470
+252,243
| +4,826% | +$23.7M |
|
750
Evolent Health
EVH
$477M
| $18.5M | 0.01% |
3,413,245
+2,628,233
| +335% | +$10.1M |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.